Advanced search
Publication Cover
Future Oncology Volume 5, 2009 - Issue 9
Submit an article Journal homepage
270
Views
0
CrossRef citations to date
0
Altmetric
Review

Targeting Phospholipase D with Small-Molecule Inhibitors as a Potential Therapeutic Approach for Cancer Metastasis

Wenjuan Sua Center for Developmental Genetics, Program in Molecular & Cellular Pharmacology and, Department of Pharmacology, Stony Brook University, NY, USAView further author information
,
Qin Chena Center for Developmental Genetics, Program in Molecular & Cellular Pharmacology and, Department of Pharmacology, Stony Brook University, NY, USAView further author information
&
Michael A Frohmanb 438 Center for Molecular Medicine, Center for Developmental Genetics and, Department of Pharmacology, Stony Brook University, Stony BrookNY11794, USA. [email protected]Correspondence[email protected]
View further author information
Pages 1477-1486 | Published online: 10 Nov 2009

Bibliography

  • Mcdermott M , WakelamMJ, MorrisAJ: Phospholipase D.Biochem. Cell Biol.82(1), 225–253 (2004).
  • Mor A , CampiG, DuGet al.: The lymphocyte function-associated antigen-1 receptor costimulates plasma membrane ras via phospholipase D2.Nat. Cell Biol.9, 712–719 (2007).
  • Zhao C , DuG, SkowronekK, Frohmanma, Bar-SagiD: Phospholipase D2-generated phosphatidic acid couples EGFR stimulation to ras activation by sos.Nat. Cell Biol.9, 707–712 (2007).
  • Delon C , ManifavaM, WoodEet al.: Sphingosine kinase 1 is an intracellular effector of phosphatidic acid.J. Biol. Chem.279(43), 44763–44774 (2004).
  • Ha SH , KimDH, KimISet al.: PLD2 forms a functional complex with MTOR/Raptor to transduce mitogenic signals.Cell. Signal.18(12), 2283–2291 (2006).
  • Jarquin-Pardo M , FitzpatrickA, GalianoFJ, FirstEA, DavisJN: Phosphatidic acid regulates the affinity of the murine phosphatidylinositol 4-phosphate 5-kinase-Iβ for phosphatidylinositol-4-phosphate.J. Cell. Biochem.100(1), 112–128 (2007).
  • Kim JH , KimJH, OhbaM, SuhPG, RyuSH: Novel functions of the phospholipase d2-phox homology domain in protein kinase c-ζ activation.Mol. Cell. Biol.25(8), 3194–3208 (2005).
  • Foster DA : Phosphatidic acid signaling to MTOR: signals for the survival of human cancer cells.Biochim. Biophys. Acta91(9), 949–955 (2009).
  • Du G , HuangP, LiangBT, FrohmanMA: Phospholipase D2 localizes to the plasma membrane and regulates angiotensin II receptor endocytosis.Mol. Biol. Cell15(3), 1024–1030 (2004).
  • Shen Y , XuL, FosterDA: Role for phospholipase D in receptor-mediated endocytosis.Mol. Cell. Biol.21(2), 595–602 (2001).
  • Corrotte M , Chasserot-GolazS, HuangPet al.: Dynamics and function of phospholipase d and phosphatidic acid during phagocytosis.Traffic7(3), 365–377 (2006).
  • Iyer SS , BartonJA, BourgoinS, KusnerDJ: Phospholipases D1 and D2 coordinately regulate macrophage phagocytosis.J. Immunol.173(4), 2615–2623 (2004).
  • Huang P , AltshullerYM, Chunqiu HouJ, PessinJE, FrohmanMA: Insulin-stimulated plasma membrane fusion of glut4 glucose transporter-containing vesicles is regulated by phospholipase D1.Mol. Biol. Cell16, 2614–2623 (2005).
  • Waselle L , GeronaRR, VitaleN, MartinTF, BaderMF, RegazziR: Role of phosphoinositide signaling in the control of insulin exocytosis.Mol. Endocrinol.19(12), 3097–3106 (2005).
  • Vicogne J , VollenweiderD, SmithJ, HuangP, FrohmanM, PessinJ: Asymmetric phospholipid distribution drives in vitro reconstituted snare-dependent membrane fusion.Proc. Natl Acad. Sci. USA103(40), 14761–14766 (2006).
  • Yang J-S , GadH, LeeSet al.: Copi vesicle fission: a role for phosphatidic acid and insight into golgi maintenance.Nat. Cell Biol.10, 1146–1153 (2008).
  • Nishikimi A , FukuharaH, SuWet al.: Sequential regulation of dock2 dynamics by two phospholipids during neutrophil chemotaxis.Science324, 384–387 (2009).
  • Rudge SA , WakelamMJ: Inter-regulatory dynamics of phospholipase D and the actin cytoskeleton.Biochim. Biophys. Acta1791(9), 856–861 (2009).
  • Du G , FrohmanMA: A lipid-signaled myosin phosphatase surge disperses cortical contractile force early in cell spreading.Mol. Biol. Cell20, 200–208 (2009).
  • Su W , YekuO, OlepuSet al.: FIPI, a phospholipase D pharmacological inhibitor that alters cell spreading and inhibits chemotaxis.Mol. Pharmacol.75, 437–446 (2009).
  • Scott SA , SelvyPE, BuckJRet al.: Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness.Nat. Chem. Biol.5(2), 108–117 (2009).
  • Powner DJ , Pettitttr, AndersonR, NashGB, WakelamMJ: Stable adhesion and migration of human neutrophils requires phospholipase D-mediated activation of the integrin CD11b/CD18.Mol. Immunol.44(12), 3211–3221 (2007).
  • Huang P , FrohmanMA: The potential for phospholipase D as a new therapeutic target.Expert Opin. Ther. Targets11, 707–716 (2007).
  • Monovich L , MugrageB, QuadrosEet al.: Optimization of halopemide for phospholipase D2 inhibition.Bioorg. Med. Chem. Lett.17(8), 2310–2311 (2007).
  • Choi SY , HuangP, JenkinsGM, ChanDC, SchillerJ, FrohmanMA: A common lipid links mfn-mediated mitochondrial fusion and snare-regulated exocytosis.Nat. Cell Biol.8, 1255–1262 (2006).
  • Katayama K , KodakiT, NagamachiY, YamashitaS: Cloning, differential regulation and tissue distribution of alternatively spliced isoforms of ADP-ribosylation-factor-dependent phospholipase d from rat liver.Biochem. J.329(Pt 3), 647–652 (1998).
  • Colley WC , AltshullerYM, Sue-LingCKet al.: Cloning and expression analysis of murine phospholipase D1.Biochem. J.326(Pt 3), 745–753 (1997).
  • Zeniou-Meyer M , ZabariN, AsheryUet al.: Phospholipase D1 production of phosphatidic acid at the plasma membrane promotes exocytosis of large dense-core granules at a late stage.J. Biol. Chem.282(30), 21746–21757 (2007).
  • Du G , AltshullerYM, VitaleNet al.: Regulation of phospholipase D1 subcellular cycling through coordination of multiple membrane association motifs.J. Cell Biol.162(2), 305–315 (2003).
  • Munck A , BohmC, SeibelNM, Hashemol HosseiniZ, HampeW: Hu-k4 is a ubiquitously expressed type 2 transmembrane protein associated with the endoplasmic reticulum.FEBS J.272(7), 1718–1726 (2005).
  • Santarius M , LeeCH, AndersonRA: Supervised membrane swimming: Small G-protein lifeguards regulate PIPK signalling and monitor intracellular PtdIns(4,5)P2 pools.Biochem. J.398(1), 1–13 (2006).
  • Cathcart MK : Signal-activated phospholipase regulation of leukocyte chemotaxis.J. Lipid Res.50(Suppl.), S231–S236 (2009).
  • Chae YC , KimJH, KimKLet al.: Phospholipase D activity regulates integrin-mediated cell spreading and migration by inducing GTP-rac translocation to the plasma membrane.Mol. Biol. Cell19(7), 3111–3123 (2008).
  • Lehman N , Di FulvioM, MccrayN, CamposI, TabatabaianF, Gomez-CambroneroJ: Phagocyte cell migration is mediated by phospholipases PLD1 and PLD2.Blood108(10), 3564–3572 (2006).
  • Carrigan SO , PinkDB, StadnykAW: Neutrophil transepithelial migration in response to the chemoattractant fmlp but not C5a is phospholipase D-dependent and related to the use of CD11b/CD18.J. Leukoc. Biol.82(6), 1575–1584 (2007).
  • Saito M , IwadateM, HigashimotoM, OnoK, TakebayashiY, TakenoshitaS: Expression of phospholipase D2 in human colorectal carcinoma.Oncol. Rep.18(5), 1329–1334 (2007).
  • Wood LD , ParsonsDW, JonesSet al.: The genomic landscapes of human breast and colorectal cancers.Science318(5853), 108–1113 (2007).
  • Joseph T , WoodenR, BryantA, ZhongM, LuZ, FosterDA: Transformation of cells overexpressing a tyrosine kinase by phospholipase D1 and D2.Biochem. Biophys. Res. Commun.289(5), 1019–1024 (2001).
  • Ahn BH , KimSY, KimEHet al.: Transmodulation between phospholipase D and c-src enhances cell proliferation.Mol. Cell. Biol.23(9), 3103–3115 (2003).
  • Lu Z , HorniaA, JosephTet al.: Phospholipase D and RalA cooperate with the epidermal growth factor receptor to transform 3y1 rat fibroblasts.Mol. Cell. Biol.20(2), 462–467 (2000).
  • Min DS , KwonTK, ParkWSet al.: Neoplastic transformation and tumorigenesis associated with overexpression of phospholipase D isozymes in cultured murine fibroblasts.Carcinogenesis22(10), 1641–1647 (2001).
  • Samuels ML , McmahonM: Inhibition of platelet-derived growth factor- and epidermal growth factor-mediated mitogenesis and signaling in 3t3 cells expressing δ raf-1:Er, an estradiol-regulated form of raf-1.Mol. Cell. Biol.14(12), 7855–7866 (1994).
  • Kerkhoff E , RappUR: Cell cycle targets of ras/raf signalling.Oncogene17(11 Reviews), 1457–1462 (1998).
  • Joseph T , BryantA, FrankelPet al.: Phospholipase D overcomes cell cycle arrest induced by high-intensity raf signaling.Oncogene21(22), 3651–3658 (2002).
  • Zhong M , ShenY, ZhengY, JosephT, JacksonD, FosterDA: Phospholipase D prevents apoptosis in v-src-transformed rat fibroblasts and mda-mb-231 breast cancer cells.Biochem. Biophys. Res. Commun.302(3), 615–619 (2003).
  • Nozawa Y : Roles of phospholipase D in apoptosis and pro-survival.Biochim. Biophys. Acta1585(2–3), 77–86 (2002).
  • Kim KO , LeeKH, KimYH, ParkSK, HanJS: Anti-apoptotic role of phospholipase D isozymes in the glutamate-induced cell death.Exp. Mol. Med.35(1), 38–45 (2003).
  • Sarbassov DD , AliSM, SabatiniDM: Growing roles for the mtor pathway.Curr. Opin. Cell Biol.17(6), 596–603 (2005).
  • Tee AR , BlenisJ: Mtor, translational control and human disease.Semin. Cell Dev. Biol.16(1), 29–37 (2005).
  • Veverka V , CrabbeT, BirdIet al.: Structural characterization of the interaction of MTOR with phosphatidic acid and a novel class of inhibitor: compelling evidence for a central role of the frb domain in small molecule-mediated regulation of mtor.Oncogene27(5), 585–595 (2008).
  • Fang Y , Vilella-BachM, BachmannR, FlaniganA, ChenJ: Phosphatidic acid-mediated mitogenic activation of MTORr signaling.Science294(5548), 1942–1945 (2001).
  • Chen Y , RodrikV, FosterDA: Alternative phospholipase d/MTOR survival signal in human breast cancer cells.Oncogene24(4), 672–679 (2005).
  • Hui L , AbbasT, PielakRM, JosephT, BargonettiJ, FosterDA: Phospholipase D elevates the level of mdm2 and suppresses DNA damage-induced increases in p53.Mol. Cell. Biol.24(13), 5677–5686 (2004).
  • Sun Y , FangY, YoonMSet al.: Phospholipase D1 is an effector of Rheb in the mtor pathway.Proc. Natl Acad. Sci. USA105(24), 8286–8291 (2008).
  • Toschi A , LeeE, XuL, GarciaA, GadirN, FosterDA: Regulation of MTORC1 and MTORC2 complex assembly by phosphatidic acid: competition with rapamycin.Mol. Cell. Biol.29(6), 1411–1420 (2009).
  • Nguyen DX , BosPD, MassagueJ: Metastasis: from dissemination to organ-specific colonization.Nat. Rev.9(4), 274–284 (2009).
  • Honda A , NogamiM, YokozekiTet al.: Phosphatidylinositol 4-phosphate 5-kinase α is a downstream effector of the small G protein arf6 in membrane ruffle formation.Cell99(5), 521–532 (1999).
  • Shen Y , ZhengY, FosterDA: Phospholipase D2 stimulates cell protrusion in v-src-transformed cells.Biochem. Biophys. Res. Commun.293(1), 201–206 (2002).
  • Zheng Y , RodrikV, ToschiAet al.: Phospholipase d couples survival and migration signals in stress response of human cancer cells.J. Biol. Chem.281(23), 15862–15868 (2006).
  • Knoepp SM , ChahalMS, XieYet al.: Effects of active and inactive phospholipase D2 on signal transduction, adhesion, migration, invasion, and metastasis in el4 lymphoma cells.Mol. Pharmacol.74(3), 574–584 (2008).
  • Kang DW , ParkMH, LeeYJet al.: Phorbol ester up-regulates phospholipase D1 but not phospholipase D2 expression through a PKC/RAS/ERK/NFκB-dependent pathway and enhances matrix metalloproteinase-9 secretion in colon cancer cells.J. Biol. Chem.283(7), 4094–4104 (2008).
  • Park MH , AhnBH, HongYK, Min doS: Overexpression of phospholipase d enhances matrix metalloproteinase-2 expression and glioma cell invasion via protein kinase C and protein kinase A/Nf-κB/SP1-mediated signaling pathways.Carcinogenesis30(2), 356–365 (2009).
  • Lukowski S , MiraJP, ZachowskiA, GenyB: Fodrin inhibits phospholipases A2, C, and D by decreasing polyphosphoinositide cell content.Biochem. Biophys. Res. Commun.248(2), 278–284 (1998).
  • Chung JK , SekiyaF, KangHSet al.: Synaptojanin inhibition of phospholipase D activity by hydrolysis of phosphatidylinositol 4,5-bisphosphate.J. Biol. Chem.272(25), 15980–15985 (1997).
  • Lee C , KimSR, ChungJK, FrohmanMA, KilimannMW, RheeSG: Inhibition of phospholipase D by amphiphysins.J. Biol. Chem.275(25), 18751–18758 (2000).
  • Venable ME , BielawskaA, ObeidLM: Ceramide inhibits phospholipase D in a cell-free system.J. Biol. Chem.271(40), 24800–24805 (1996).
  • Abousalham A , LiossisC, O’BrienL, Brindleydn: Cell-permeable ceramides prevent the activation of phospholipase D by ADP-ribosylation factor and RhoA.J. Biol. Chem.272(2), 1069–1075 (1997).
  • Yoshimura S , SakaiH, OhguchiKet al.: Changes in the activity and mRNA levels of phospholipase D during ceramide-induced apoptosis in rat c6 glial cells.J. Neurochem.69(2), 713–720 (1997).
  • Garcia A , ZhengY, ZhaoCet al.: Honokiol suppresses survival signals mediated by ras-dependent phospholipase D activity in human cancer cells.Clin. Cancer Res.14(13), 4267–4274 (2008).
  • Pannequin J , DelaunayN, DaridoCet al.: Phosphatidylethanol accumulation promotes intestinal hyperplasia by inducing zonab-mediated cell density increase in response to chronic ethanol exposure.Mol. Cancer Res.5(11), 1147–1157 (2007).
  • Lewis JA , ScottSA, LavieriRet al.: Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part I: Impact of alternative halogenated privileged structures for pld1 specificity.Bioorg. Med. Chem. Lett.19(7), 1916–1920 (2009).
  • Lavieri R , ScottSA, LewisJAet al.: Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part II. Identification of the 1,3,8-triazaspiro[4,5]decan-4-one privileged structure that engenders PLD2 selectivity.Bioorg. Med. Chem. Lett.19(8), 2240–2243 (2009).
  • Uchida N , OkamuraS, NagamachiY, YamashitaS: Increased phospholipase D activity in human breast cancer.J. Cancer Res. Clin. Oncol.123(5), 280–285 (1997).
  • Noh DY , AhnSJ, LeeRAet al.: Overexpression of phospholipase D1 in human breast cancer tissues.Cancer Lett.161(2), 207–214 (2000).
  • Yamada Y , HamajimaN, KatoTet al.: Association of a polymorphism of the phospholipase D2 gene with the prevalence of colorectal cancer.J. Mol. Med.81(2), 126–131 (2003).
  • Uchida N , OkamuraS, KuwanoH: Phospholipase D activity in human gastric carcinoma.Anticancer Res.19(1B), 671–675 (1999).
  • Zhao Y , EharaH, AkaoYet al.: Increased activity and intranuclear expression of phospholipase d2 in human renal cancer.Biochem. Biophys. Res. Commun.278(1), 140–143 (2000).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.